Search results
Results From The WOW.Com Content Network
18,000 (2023) [1] Website. lonza .com. Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland.
US$750 million (2011) [2] Number of employees. 3,600 (2016) [1] Parent. Lonza Group. Website. capsugel .com. Capsugel is a company that manufactures and sells two-piece hard gelatin drug capsules. [3] : 703 Capsugel also sells equipment for filling empty and liquid capsules, as well as equipment for sealing liquid capsules.
Bangladesh Blade Factory Limited. Bangladesh Chemical Industries Corporation. Bangladesh Communication Satellite Company Limited. Bangladesh Diesel Plant Limited. Bangladesh Film Development Corporation. Bangladesh Fisheries Development Corporation. Bangladesh Forest Industries Development Corporation. Bangladesh Gas Fields Company Limited.
July 25, 2024 at 3:19 AM. By Isabel Demetz and Andrey Sychev. (Reuters) -Swiss contract drug manufacturer Lonza reported a smaller-than-expected decline in first-half profit on Thursday, as a ...
Lonza said on Tuesday it has capacity to fill syringes to serve makers of highly popular new weight-loss drugs in a class known as GLP-1, though it does not produce the active ingredient in those ...
Lonza Group Ag (LZAGY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Alusuisse was a Swiss industrial group founded as Aluminium Industrie Aktien in 1898, Zurich, Switzerland. The organisation was named Schweizerische Aluminium AG from 1963, Alusuisse-Lonza Holding AG from 1990, and Algroup from 1998. From the 1900s, it became a significant employer in the Valais canton through its aluminum production activities ...
Lonza Group has extended a collaboration with a major biopharmaceutical industry client for the supply of an antibody drug conjugate (ADC) against hard-to-treat cancers, the Swiss contract ...